| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.016 | 0.8 |